NCT00624819View on ClinicalTrials.gov

Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

524

Participants

Timeline

Start Date

March 3, 2008

Primary Completion Date

June 2, 2008

Study Completion Date

June 2, 2008

Conditions
Infections, StreptococcalStreptococcus Pneumoniae Vaccines
Interventions
BIOLOGICAL

GSK1024805A

No vaccination in this trial

BIOLOGICAL

Prevenar

No vaccination in this trial

BIOLOGICAL

Infanrix hexa

No vaccination in this trial

BIOLOGICAL

Havrix

No vaccination in this trial

BIOLOGICAL

Varilrix

No vaccination in this trial

Trial Locations (6)

85-021

GSK Investigational Site, Bydgoszcz

39-200

GSK Investigational Site, Dębica

31-503

GSK Investigational Site, Krakow

56-400

GSK Investigational Site, Oleśnica

61-709

GSK Investigational Site, Poznan

41-103

GSK Investigational Site, Siemianowice Śląskie

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY